MD Spiro prides itself on not only offering incredible spirometry products for your practice, but also prides itself on providing articles and industry updates for our customers. Below is a new study showing you trends, R&D progress, and predicted revenues in Asthma and COPD Therapies. So where’s the asthma and COPD therapies market heading? Visiongain’s…
Today, is Earth Day. A statement released by the White House outlines an initiative to combat the health-related effects of climate change, with an emphasis on chronic obstructive pulmonary disease (COPD) and asthma. “The Centers for Disease Control and Prevention (CDC) is releasing an Adaptation in Action Report highlighting successful actions state and local…
Diabetics now have a new option thanks to the breakthrough new medication AFREZZA®, an inhaled insulin now available by prescription. The labeling for AFREZZA®, mandates spirometry testing (specifically FEV1) to rule out chronic lung disease prior to initiating therapy, six months after initiation and every year thereafter1. MD Spiro offers a number of spirometer options…
Reducing the risks of e-cigarettes to smokers, encouraging the smoking-cessation potential, and restricting access by nonsmokers offer a regulatory trifecta that can be implemented immediately, according to a former FDA official. The “roadmap” to effective regulation hinges on implementation of the pending FDA deeming rule, which is expected to go into effect later this year….
The draft guideline – NICE’s first on asthma – reinforces recommendations made in the 2014 BTS/SIGN asthma guideline, which also supports spirometry as the preferred initial test to assess the presence and severity of airflow obstruction. A number of methods and assessments are available to determine the likelihood of asthma. These include measures of airflow…
Join the American Lung Association in its effort to eliminate tobacco-caused death and disease! By taking action to prevent and reduce tobacco use in your state, you are standing with the American Lung Association to advance the fight against lung disease. As part of the American Lung Association Action Network, you can also take action…
In this New Year, it is important for us to be educated about new studies that have come out in reference to airway management, asthma, COPD, and more. A higher incidence of inflammatory bowel disease (IBD) has been found in persons with airway diseases, such as asthma and COPD, in a study published online ahead…
The Forum of International Respiratory Societies (FIRS) is continuing to mobilize its members to raise awareness of COPD and help prevent the risk factors that cause it. 210 million people have COPD worldwide, causing the death of at least 2.9 million people each year. It is the sixth major cause of death and disability in…